1. Home
  2. BNTX vs TEVA Comparison

BNTX vs TEVA Comparison

Compare BNTX & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTX
  • TEVA
  • Stock Information
  • Founded
  • BNTX 2008
  • TEVA 1901
  • Country
  • BNTX Germany
  • TEVA Israel
  • Employees
  • BNTX N/A
  • TEVA N/A
  • Industry
  • BNTX Biotechnology: Biological Products (No Diagnostic Substances)
  • TEVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNTX Health Care
  • TEVA Health Care
  • Exchange
  • BNTX Nasdaq
  • TEVA Nasdaq
  • Market Cap
  • BNTX 23.9B
  • TEVA 18.7B
  • IPO Year
  • BNTX 2019
  • TEVA N/A
  • Fundamental
  • Price
  • BNTX $95.87
  • TEVA $16.34
  • Analyst Decision
  • BNTX Strong Buy
  • TEVA Strong Buy
  • Analyst Count
  • BNTX 17
  • TEVA 6
  • Target Price
  • BNTX $146.17
  • TEVA $24.00
  • AVG Volume (30 Days)
  • BNTX 877.6K
  • TEVA 11.9M
  • Earning Date
  • BNTX 03-10-2025
  • TEVA 05-07-2025
  • Dividend Yield
  • BNTX N/A
  • TEVA N/A
  • EPS Growth
  • BNTX N/A
  • TEVA N/A
  • EPS
  • BNTX N/A
  • TEVA N/A
  • Revenue
  • BNTX $2,848,224,455.00
  • TEVA $16,544,000,000.00
  • Revenue This Year
  • BNTX N/A
  • TEVA $5.31
  • Revenue Next Year
  • BNTX N/A
  • TEVA $1.18
  • P/E Ratio
  • BNTX N/A
  • TEVA N/A
  • Revenue Growth
  • BNTX N/A
  • TEVA 4.40
  • 52 Week Low
  • BNTX $76.53
  • TEVA $12.51
  • 52 Week High
  • BNTX $131.49
  • TEVA $22.80
  • Technical
  • Relative Strength Index (RSI)
  • BNTX 38.08
  • TEVA 44.87
  • Support Level
  • BNTX $98.43
  • TEVA $16.06
  • Resistance Level
  • BNTX $102.82
  • TEVA $16.89
  • Average True Range (ATR)
  • BNTX 4.04
  • TEVA 0.62
  • MACD
  • BNTX -0.88
  • TEVA 0.18
  • Stochastic Oscillator
  • BNTX 10.51
  • TEVA 70.85

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: